Scinovex
articleTop 1% cited

Ranibizumab for Macular Edema following Central Retinal Vein Occlusion

Ophthalmology · 2010 · Vol. 117(6) · pp. 1124–1133.e1
Retinal Diseases and TreatmentsRetinal and Optic ConditionsOcular Diseases and Behçet’s SyndromeRanibizumabMedicineCentral retinal vein occlusionMacular edemaOphthalmologyVisual acuityRandomized controlled trialConfidence intervalSurgeryBevacizumab

MeSH terms

RanibizumabAdultAgedAged, 80 and overAntibodies, MonoclonalDouble-Blind MethodFemaleFollow-Up StudiesHumansInjectionsMacular EdemaMaleMiddle AgedProspective StudiesRetinal Vein Occlusion
Citations
1,138
FWCI
78.17
field-weighted impact
References
45
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.